We are live on ! Find out more
GT

Glenview Trust Portfolio holdings

AUM $6.37B
1-Year Est. Return 23.72%
This Fund
S&P 500
This Quarter Est. Return
+5.98%
1 Year Est. Return
+23.72%
3 Year Est. Return
+87.8%
5 Year Est. Return
+115.86%
10 Year Est. Return
AUM
$5.2B
AUM Growth
+$228M
Cap. Flow
-$26.5M
Cap. Flow %
-0.51%
Top 10 Hldgs %
34.38%
Holding
485
New
22
Increased
199
Reduced
181
Closed
11

Top Sells

Rank Stock Value
1
BF.B icon
Brown-Forman Class B
BF.B
+$81.1M
2
TMO icon
Thermo Fisher Scientific
TMO
+$14.5M
3
DLTR icon
Dollar Tree
DLTR
+$14.3M
4
NVDA icon
NVIDIA
NVDA
+$12.5M
5
LLY icon
Eli Lilly
LLY
+$2.75M

Sector Composition

Rank Sector Weight
1 Technology 24.1%
2 Healthcare 11.1%
3 Financials 9.78%
4 Consumer Staples 6.93%
5 Consumer Discretionary 6.31%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRVL icon
26
Marvell Technology
MRVL
$173B
$43.3M 0.83%
600,716
+32,669
+6% +$2.26M
IBDP
27
DELISTED
iShares iBonds Dec 2024 Term Corporate ETF
IBDP
$41.4M 0.8%
1,640,832
-29,968
-2% -$753K
MRK icon
28
Merck
MRK
$322B
$40.5M 0.78%
356,273
+12,742
+4% +$1.51M
MCD icon
29
McDonald's
MCD
$192B
$38.6M 0.74%
126,748
+2,345
+2% +$646K
ADI icon
30
Analog Devices
ADI
$180B
$35.6M 0.69%
154,735
+12,689
+9% +$2.86M
LOW icon
31
Lowe's Companies
LOW
$117B
$35.6M 0.68%
131,347
+11,932
+10% +$2.89M
CVX icon
32
Chevron
CVX
$391B
$34.8M 0.67%
236,183
-4,079
-2% -$607K
IBM icon
33
IBM
IBM
$209B
$34.6M 0.67%
156,555
+78
+0% +$15.3K
XOM icon
34
ExxonMobil
XOM
$641B
$33M 0.63%
281,445
-739
-0.3% -$85.3K
KO icon
35
Coca-Cola
KO
$377B
$32.7M 0.63%
455,319
+2,515
+0.6% +$172K
BRK.B icon
36
Berkshire Hathaway Class B
BRK.B
$1.1T
$32.4M 0.62%
70,347
+1,481
+2% +$655K
UNP icon
37
Union Pacific
UNP
$173B
$31.9M 0.61%
129,582
+105
+0.1% +$25.5K
SBUX icon
38
Starbucks
SBUX
$120B
$31.6M 0.61%
324,530
-5,280
-2% -$453K
LMT icon
39
Lockheed Martin
LMT
$134B
$31.2M 0.6%
53,370
+746
+1% +$401K
V icon
40
Visa
V
$684B
$30.8M 0.59%
111,953
+927
+0.8% +$251K
BF.B icon
41
Brown-Forman Class B
BF.B
$13.2B
$30.4M 0.59%
618,258
-1,804,550
-74% -$81.1M
CHDN icon
42
Churchill Downs
CHDN
$5.91B
$30M 0.58%
222,093
-1,850
-0.8% -$256K
UNH icon
43
UnitedHealth
UNH
$380B
$27.9M 0.54%
47,796
+4,391
+10% +$2.48M
EW icon
44
Edwards Lifesciences
EW
$49.6B
$27.4M 0.53%
415,544
-11,215
-3% -$815K
CAT icon
45
Caterpillar
CAT
$378B
$26.8M 0.52%
68,575
+1,517
+2% +$524K
ALL icon
46
Allstate
ALL
$68.6B
$26.6M 0.51%
140,295
-997
-0.7% -$177K
CSX icon
47
CSX Corp
CSX
$93.5B
$25.7M 0.49%
743,784
+63,561
+9% +$2.16M
JNJ icon
48
Johnson & Johnson
JNJ
$622B
$25.5M 0.49%
157,390
+252
+0.2% +$40.1K
VNQ icon
49
Vanguard Real Estate ETF
VNQ
$39.2B
$25.2M 0.49%
259,069
+28,549
+12% +$2.63M
CSCO icon
50
Cisco
CSCO
$457B
$25.1M 0.48%
471,076
-14,134
-3% -$687K

Similar funds

Glenview Trust's Q3 2024 Portfolio in Review

As of Q3 2024, Glenview Trust held 485 positions worth $5.2B, up 4.6% from $4.97B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Glenview Trust's Q3 2024 filing shows 22 new, 199 increased, 181 reduced and 11 closed positions. Its largest new stake was State Street SPDR S&P 600 Small Cap Value ETF: 5,496 shares worth $477K. The largest sale was Brown-Forman Class B, an estimated $81.1M.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Healthcare and Financials.

  • Glenview Trust's largest Q3 2024 buy was State Street SPDR S&P 600 Small Cap Value ETF: 5,496 shares worth $477K.
  • Glenview Trust added most to Becton Dickinson in Q3 2024, an estimated $17.3M increase.
  • Glenview Trust's biggest Q3 2024 reduction was Brown-Forman Class B, cutting an estimated $81.1M.
  • Glenview Trust fully exited Microchip Technology in Q3 2024, selling an estimated $617K.
  • Glenview Trust's ten largest holdings make up 34% of its $5.2B portfolio in Q3 2024.
  • Glenview Trust opened 22 new positions and closed 11 in Q3 2024.
  • Glenview Trust's portfolio value rose 4.6% quarter-over-quarter to $5.2B.

Based on Glenview Trust's 13F filing for Q3 2024, filed 12 Nov 2024.